Drug intelligence / Profile preview

liposomal bupivacaine + bupivacaine

Development stage
Unknown
Lead developer
Pacira BioSciences
Modality
Nanoparticles → Drug Delivery Systems, Small Molecules
Administration
Local Infiltration, Nerve Block, Perineural Injection, Intra-articular Injection
01

Overview

This is a combination of two local anesthetic formulations—liposomal bupivacaine and conventional bupivacaine (bupivacaine hydrochloride). Liposomal bupivacaine is an extended-release formulation in which the active drug is encapsulated within multivesicular liposomes, allowing for prolonged release and sustained analgesic effect at the site of administration. Conventional bupivacaine provides rapid onset but shorter duration of action. The combination aims to provide both immediate and extended postoperative pain control by leveraging the fast onset of conventional bupivacaine with the prolonged effect of liposomal bupivacaine. Both act as sodium channel blockers, inhibiting nerve impulse transmission to produce local or regional anesthesia or analgesia, primarily used in surgical settings for postsurgical pain management[1][4][6][9].

Brand names
Exparel
Other names
bupivacaine liposomebupivacaine liposomal suspensionbupivacaine
02

Targets

SCN2A (Voltage-gated sodium channel protein type 2 subunit alpha)SCN9A (Sodium channel protein type 9 subunit alpha)KATP channel (ATP-sensitive potassium channel)SCN5A (Sodium channel protein type 5 subunit alpha)

Beyond the preview

Go deeper on liposomal bupivacaine + bupivacaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on liposomal bupivacaine + bupivacaine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call